|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:administeredBy
|
injection
nasal spray
|
|
gptkbp:approvedBy
|
gptkb:World_Health_Organization
gptkb:U.S._Food_and_Drug_Administration
|
|
gptkbp:boosterRecommended
|
no (annual dose instead)
|
|
gptkbp:broadcastOn
|
once per year
|
|
gptkbp:canBeAdministeredDuring
|
pregnancy
|
|
gptkbp:canBeAdministeredTo
|
people with chronic diseases
immunocompromised individuals (inactivated only)
|
|
gptkbp:canBeGivenWith
|
other vaccines
|
|
gptkbp:contains
|
gptkb:live_attenuated_influenza_virus
inactivated influenza virus
recombinant influenza protein
|
|
gptkbp:contraindication
|
people with severe egg allergy (some formulations)
|
|
gptkbp:cost
|
varies by country
|
|
gptkbp:developedBy
|
multiple manufacturers
|
|
gptkbp:distribution
|
global
|
|
gptkbp:effect
|
varies by season
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Influenza vaccine
|
|
gptkbp:includedIn
|
national immunization programs
|
|
gptkbp:introducedIn
|
1940s
|
|
gptkbp:mayInclude
|
gptkb:thimerosal_(some_formulations)
antibiotics (trace amounts)
formaldehyde (trace amounts)
|
|
gptkbp:notEffectiveAgainst
|
gptkb:COVID-19
common cold
|
|
gptkbp:notRecommendedFor
|
infants under 6 months
|
|
gptkbp:prevention
|
influenza
|
|
gptkbp:publicHealthGoal
|
herd immunity
|
|
gptkbp:recommendation
|
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization
children
pregnant women
elderly
healthcare workers
|
|
gptkbp:reduces
|
hospitalization due to influenza
influenza-related deaths
|
|
gptkbp:routeOfAdministration
|
intramuscular
intranasal
|
|
gptkbp:sideEffect
|
fever
muscle aches
soreness at injection site
|
|
gptkbp:storage
|
refrigerated
|
|
gptkbp:targetedVirus
|
gptkb:influenza_A
gptkb:influenza_B
|
|
gptkbp:type
|
quadrivalent
trivalent
|
|
gptkbp:updated
|
annually
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Influenza
|
|
gptkbp:bfsLayer
|
4
|